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Hashimoto’s thyroiditis has been reported to be associated with many neoplastic and nonneoplastic thyroid pathologies. This
retrospective study aims to determine the demographic proﬁle of Hashimoto’s thyroiditis in Sri Lankans, document ancillary
pathologies in Hashimoto’s thyroiditis, and determine whether there is an increased risk of occurrence of malignancies, benign
neoplasms,andnonneoplasticbenignlesionsinHashimoto’sthyroiditisbycomparingwiththyroidsshowingmultinodulargoiters,
follicular adenomas, and colloid nodules. The mean age of Hashimoto’s thyroiditis is 43.3 years with the majority in the 41 to 60
year age group and a female to male ratio of 10.3:1. This study revealed a statistically signiﬁcant increase of thyroid malignancies
in association with Hashimoto’s thyroiditis. The association of Papillary carcinoma, Non-Hodgkin’s lymphoma, and Hurthle cell
adenoma with Hashimoto’s thyroiditis was statistically signiﬁcant.
1.Introduction
Hashimoto’s thyroiditis, an autoimmune disease of the
thyroidglandiscommonlyencounteredinfemalesofmiddle
age and aﬀects approximately 5% of the population [1–
3]. The incidence of Hashimoto’s thyroiditis in the west is
approximately 0.3–1.5 cases per 1,000 population per year
[4]. A study conducted in Malaysia has shown interesting
ethnic diﬀerences in Hashimoto’s thyroiditis such as high
prevalenceamongIndians whencomparedwithChinese and
Malay nationals [5].
Hashimoto’s thyroiditis is deﬁned histologically by the
presence of diﬀuse lymphocytic inﬁltrates, lymphoid follicles
with reactive germinal centers, Hurthle cell change of the
follicular epithelial cells, parenchymal atrophy, and ﬁbrosis.
Hashimoto’s thyroiditis has been reported to be associated
withmanyneoplasticandnonneoplasticthyroidpathologies.
The rate of occurrence of thyroid malignancies in patients
withHashimoto’sthyroiditisrangesfrom0.5%to14%[1,6].
ThemorecommonlyreportedmalignanciesareB-andT-cell
Non-Hodgkin’s lymphoma and Papillary carcinoma of the
thyroid [2, 7]. Other neoplasms such as follicular carcinoma
[2], anaplastic thyroid carcinoma [2], medullary carcinoma
[2, 6], Hodgkin’s lymphoma [7], mucoepidermoid thyroid
carcinoma [8], and primary squamous cell carcinoma [9]
have also been reported. A review of the literature revealed
coexistence with many benign lesions such as intrathyroidal
lymphoepithelial cysts [10, 11], Riedel’s thyroiditis [12],
benign thyroid nodules, and goiter [13] and plasma cell
granuloma [14].
There is long-standing controversy regarding the asso-
ciation between Hashimoto’s thyroiditis and follicular cell-
derived thyroid tumours. This association was ﬁrst proposed
more than 50 years ago by Dailey et al. who found a
signiﬁcantly higher frequency of thyroid carcinomas and
adenomas in surgically removed glands with Hashimoto’s
thyroiditis than in glands unaﬀected by this disease [15].
Most of the malignancies found in their series were papil-
lary carcinomas. The subsequent studies yielded conﬂicting
results, reporting either very high or low incidence of thy-
roid carcinoma in association with Hashimoto’s thyroiditis
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The objective of this study is to determine the demo-
graphic proﬁle of Hashimoto’s thyroiditis in Sri Lankans,
detect the ancillary pathologies associated with Hashimoto’s
thyroiditis, and to determine whether there is an increased
risk of occurrence of malignancies, benign neoplasms, and
nonneoplastic benign lesions in Hashimoto’s thyroiditis.
2.MaterialsandMethods
A retrospective review of 5357 consecutive histopathology
records of total and subtotal thyroidectomy specimens
received over a ﬁfteen year period formed the basis of
this study. Data on demographic proﬁle (age and gender),
presence or absence of Hashimoto’s thyroiditis, and the
type of ancillary pathology were gathered. No clinical data
were available. A total of 349 Hashimoto’s thyroiditis cases
were collected. 2663 multinodular goiters, 1166 follicular
adenomas, and 631 colloid nodules were gathered for
comparisonwithHashimoto’sthyroiditis.Allcategorieswere
stratiﬁed according to age groups of 0–20 years, 21–40
years, 41–60 years, and 61 or more than 61 years. Ancillary
pathologies seen in each of these categories were recorded
in these age groups. The gender and age distribution of
Hashimoto’s thyroiditis was analysed. The percentages of
the ancillary pathologies seen in the speciﬁed age groups
were calculated for all the categories. To determine whether
there is an increased occurrence of ancillary pathologies in a
background of Hashimoto’s thyroiditis age-matched groups
of Hashimoto’s thyroiditis were comparatively analyzed with
thyroids aﬀected by multinodular goiters, follicular adeno-
mas, and colloid nodules. The statistical analysis of the data
was carried out using the Minitab version 13.20 software.
When the sample size was too small Fishers exact test
(FET) was performed. The statistical associations between
categorieswerecalculatedatalevelofsigniﬁcance(α)of0.05.
3. Results
The incidence of Hashimoto’s thyroiditis in this study of
5357 cases is 6.51%, which is similar to the incidence (6.6%)
reported by Chesky as quoted by Carson et al. [19]. Of
the 349 cases 318 (91.12%) were females and 31 (8.88%)
were males indicating a female to male ratio of 10.3:1. The
age ranged from 8 to 89 years with a mean age of 43.3
years. The majority of the cases were seen in the 41–60 year
age group (53.3%) followed by 21–40 years (34.96%), 61
years and above (6.02%) and 0–20 years (3.44%). A female
predominance was seen in all the age groups. In the 0–20
year age group only females were aﬀected by Hashimoto’s
thyroiditis. In all the other age groups more than 85%
c o m p r i s e do ff e m a l e s( Table 1).
The ancillary pathologies found in association with
Hashimotos’ thyroiditis were papillary carcinoma (PC),
follicular carcinoma (FC), medullary carcinoma (MC),
anaplastic carcinoma (AnC), Non-Hodgkin’s lymphoma
(NHL), follicular adenoma (FA), Hurthle cell adenoma
(HA), multinodular goiter (MNG), colloid goiter (CG), col-
loid nodule (CN), hyperplastic nodule (HypN), and benign
Table 1: Gender distribution of Hashimoto’s thyroiditis. (Percent-
ages from a total of 349 Hashimoto’s thyroiditis is shown within
brackets).
Age group (years) Females Males Total
0–20 12 (3.44%) 0 12
21–40 109 (31.23%) 13 (3.72%) 122
41–60 171 (48.99%) 15 (4.29%) 186
61 and above 18 (5.16%) 3 (0.86%) 21
Not known 8 (2.29%) 0 8
cysts (Cyst). In our study 142 cases (40.69%) displayed an
ancillary pathology. Of the 349 cases an associated malig-
nancy was seen in 46 cases (13.18%). Of the malignancies
72% were papillary carcinomas, followed by follicular car-
cinoma (17%), Non-Hodgkin’s lymphoma (6%), medullary
carcinoma (2%), and anaplastic carcinoma (2%). As such
the commonest epithelial malignancy seen in Hashimoto’s
thyroiditis was papillary carcinoma. An associated benign
neoplasm was detected in 54 cases (15.47%). Of this 66.67%
were follicular adenomas and 33.33% were Hurthle cell
adenomas.In67cases(19.2%)anancillarybenignlesionwas
seen. This included multinodular goiters (52.24%), colloid
nodule (34.33%), hyperplastic nodule (7.46%), benign cysts
(4.48%), and colloid goiter (1.5%) ( Table 2).
Of the 142 cases in which an ancillary pathology
was detected 17.6% showed multiple pathologies. Papillary
carcinoma was seen as a dual pathology with Hurthle
cell adenoma (2.1%), multinodular goiter (2.1%), follicular
carcinoma(1.4%),follicularadenoma(0.7%),andanaplastic
carcinoma (0.7%). Hurthle cell adenoma was seen simul-
taneously with follicular carcinoma (0.7%), multinodular
goiter (0.7%) and follicular adenoma (0.7%). The other
dual pathologies detected were, follicular adenoma with
colloid nodule (0.7%) and multinodular goiter (1.4%) and
multinodular goiter with colloid nodule (0.7%) and hyper-
plastic nodule (1.4%). Several other multiple pathologies
were also identiﬁed. Papillary carcinoma and Hurthle cell
adenoma was seen with follicular adenoma (0.7%), colloid
nodule (0.7%), and follicular carcinoma (0.7%). Papillary
carcinoma with follicular adenoma and multinodular goiter
(0.7%) and multinodular goiter and colloid nodule with
follicular adenoma (0.7%) and hyperplastic nodule (0.7%)
were observed.
With reference to gender distribution of the ancillary
pathologies females showed a higher percentage of malig-
nancies (91.3%), benign neoplasms (75.93%) as well as
benign nonneoplastic lesions (85.07%) than males which
were statistically signiﬁcant (P<. 001). When the ancillary
pathologies were analyzed separately all ancillary pathologies
except Hurthle cell adenoma and anaplastic carcinoma
occurred in higher percentages in females. Medullary car-
cinoma, multinodular goiter, colloid goiter, and benign
cysts were seen exclusively in females. 96.97% of papillary
carcinomas, 91.67% of follicular adenomas, 87.5% of fol-
licular carcinomas, 66.67% of Non-Hodgkin’s lymphomas,
65.22% of colloid nodules and 60% of hyperplastic nodules,Journal of Thyroid Research 3
Table 2: Number of ancillary pathologies associated with Hashimoto’s thyroiditis
Age(years) PC FC MC AnC NHL FA HA MNG CG CN HyN Cysts
0–20 (12) 1 0 0 0 0 0 0 1 0 2 0 0
21–40 (122) 11 3 1 0 3 11 8 10 0 8 0 1
41–60 (186) 19 4 0 1 0 21 9 20 1 11 5 2
>61 (21) 2 0 0 0 0 4 0 3 0 1 0 0
N o t k n o w n 0100 0 0 1 1 010 0
Total 33 8 1 1 3 36 18 35 1 23 5 3
% 9.46 2.29 0.29 0.29 0.86 10.32 5.16 10.03 0.29 6.59 1.43 0.86
46 (13.18%) 54 (15.47%) 67 (19.2%)
were detected in females. The two instances where a male
predominancewasseenwereHurthlecelladenoma(57.90%)
and anaplastic carcinoma (100%).
When considering the distribution of ancillary patholo-
gies in the speciﬁed age groups it was evident that the only
malignancy detected in the 0–20 years and 61 years and
above was papillary carcinoma. The frequency of papillary
carcinoma in the speciﬁed age groups varied between
8.33% (0–20 years) and 10.23% (41–60 years). Follicular
carcinomas have occurred between 21–60 years of age and
all Non-Hodgkin’s lymphomas were seen in the 21–40 year
age group. A single case each of anaplastic carcinoma and
medullary carcinoma was seen in the 41–60 years and 21–
40 years age group respectively. Of the benign neoplasms
Hurthle cell adenoma was seen between 21–60 years and
follicular adenoma was seen in patients above 20 years. Of
the nonneoplastic benign lesions multinodular goiters and
colloid nodules were seen in association with Hashimoto’s
thyroiditis in all the age groups. Colloid goiter, hyperplastic
nodule, and benign cysts which included a branchial cyst
were seen in the 41–60 year age group.
The comparison of the percentages of ancillary patholo-
giesseeninassociationwithHashimoto’sthyroiditisandthy-
roids aﬀected by multinodular goiters, follicular adenomas,
and colloid nodules is shown in Table 3.
Papillary carcinoma, medullary carcinoma, anaplastic
carcinoma, Non-Hodgkin’s lymphoma, Hurthle cell ade-
noma, and benign cysts were seen in higher percentages
in association with Hashimoto’s thyroiditis when compared
with thyroids aﬀected by other pathologies (Table 3). A
statistically signiﬁcant increase in occurrence of papillary
carcinoma,Non-Hodgkin’slymphoma,andHurthlecellade-
noma were seen in Hashimoto’s thyroiditis when compared
with thyroids aﬀected by multinodular goiters, follicular
adenomas, and colloid nodules. A statistically signiﬁcant
association of colloid nodule with Hashimoto’s thyroiditis
was seen when compared with multinodular goiters.
The ancillary pathologies in Hashimoto’s thyroiditis
were then compared with age-matched groups of thyroids
aﬀected by multinodular goiter, follicular adenoma, and
colloid nodule. A statistically signiﬁcant increase of papillary
carcinoma in the 21–40 year (P value = .008) and 41–60 year
(P value <. 001) age group, Non-Hodgkin’s lymphoma (FET
P value = .001) in the 21–40 year age group, Hurthle cell
adenoma in the age groups 21–40 years (P value = .008), and
41–60 years (P value = .003) and follicular adenoma in >61
yearagegroup(P value = .02)werenotedinassociationwith
Hashimoto’s thyroiditis when compared with multinodular
goiters. When Hashimoto’s thyroiditis and follicular adeno-
mas were comparatively analyzed papillary carcinoma in the
21–40year(FETP value= .019)and41–60year(FETP value
= .007) age groups, Non-Hodgkin’s lymphoma (FET P value
= .004) in the 21–40 year age group, Hurthle cell adenoma
in the age groups 21–40 years (FET P value <. 001), and
41–60 years (FET P value <. 001) occurred in signiﬁcantly
higher frequencies in Hashimoto’s thyroiditis. Comparative
analysisbetweenHashimoto’sthyroiditisandcolloidnodules
revealed a signiﬁcantly increased occurrence of papillary
carcinoma (FET P value = .016) in the 21–40 year age group,
Non-Hodgkin’s lymphoma (FET P value = .033) in the 21–
40 year age group, Hurthle cell adenoma in the age groups
21–40 years (FET P value <. 001) and 41–60 years (FET P
value <. 012) in association of Hashimoto’s thyroiditis.
4. Discussion
The gender distribution of Hashimoto’s thyroiditis revealed
a female predominance with a female to male ratio of 10.3:1
which is similar to the reported female to male ratio that
r a n g e sf r o m4:1t o1 5:1[ 2, 3]. Most cases of Hashimoto’s
thyroiditis were detected in the 5th and 6th decades of life
with 53.3% of the cases occurring in this age group followed
by 3rd to 4th decades (35%). These ﬁndings are similar
to those of other studies conducted in the west in which
Hashimoto’s thyroiditis is reported to be diagnosed between
4th to 6th decades of life [2].
According to the present study malignancies as well as
benign neoplasms coexisted with Hashimoto’s thyroiditis.
Papillary carcinomas have occurred in all the age groups,
whereasfollicularcarcinoma,medullarycarcinoma,anaplas-
tic carcinoma, Non-Hodgkin’s lymphoma, Hurthle cell ade-
noma and follicular adenoma, were seen in patients over 20
yearsofage.Femalesappearedtobeatagreaterriskofhaving
an ancillary malignant or benign lesion in a background of
Hashimoto’s thyroiditis. Of note is the higher percentage of
Hurthle cell adenomas and anaplastic carcinomas in males.
In our study of 349 cases with Hashimoto’s thyroiditis,
40.69% had one or more associated pathologies. Of this4 Journal of Thyroid Research
Table 3: Comparison of the percentages of ancillary pathologies seen in association with Hashimoto’s thyroiditis and thyroids aﬀected by
multinodular goiters (MNG), follicular adenomas (FA), and colloid nodules (CN).
PC FC MC AnC NHL FA HA MNG CG CN HyN Cysts
HT 9.46 2.29 0.27 0.27 0.86 10.32 5.16 10.03 0.27 6.59 1.43 0.86
MNG 1.61 1.16 0.08 0.08 0.04 8.26 0.45 — — 2.93 1.20 0.41
FA 3.17 2.06 0 0 0 — 1.03 18.87 0.26 7.12 1.46 0.43
CN 5.07 3.01 0 0 0 13.15 0.95 12.36 0.63 — 0.79 0.63
17.6% showed two or more pathologies associated with
Hashimoto’s thyroiditis. Papillary carcinoma was seen in
combination with Hurthle cell adenoma, multinodular goi-
ter, follicular carcinoma, follicular adenoma, and anaplastic
carcinoma. Hurthle cell adenoma was seen simultaneously
with follicular carcinoma, multinodular goiter, and follicular
adenoma. The other concurrent pathologies detected were
follicular adenoma with colloid nodule and multinodular
goiter and multinodular goiter with colloid nodule and
hyperplastic nodule.
Since the initial description by Marjolin in 1828, chronic
inﬂammation has been increasingly recognized to play
a major role in development of cancer. However the
association between Hashimoto’s thyroiditis and thyroid
malignancies remain controversial [2]. We observed that
in 349 patients with Hashimoto’s thyroiditis 13.18% had
coexistent malignancies. The malignancies detected were
papillary carcinoma (9.46%), follicular carcinoma (2.29%),
Non-Hodgkin’s lymphoma (0.86%), medullary carcinoma
(0.29%),andanaplasticcarcinoma(0.29%).Thepercentages
of thyroid malignancies in thyroids aﬀected by multinodular
goiter, follicular adenoma and colloid nodule were 3.04%,
5.4% and 8.34%, respectively. The increase of thyroid
malignancies in Hashimoto’s thyroiditis was statistically
signiﬁcant. There is lack of consensus as to whether there
is an increased incidence of thyroid cancer associated with
Hashimoto’s thyroiditis [2, 15–17, 19]. According to our
study the percentage of thyroid epithelial malignancies in
Hashimoto’s thyroiditis was 12.32% compared with 3%
in multinodular goiters, 5.32% in follicular adenomas,
and 8.24% in colloid nodules. The higher percentage of
thyroid epithelial malignancies in Hashimoto’s thyroiditis
was statistically signiﬁcant. The coincidence of Hashimoto’s
thyroiditis and thyroid carcinoma will be inﬂuenced by
geography, histologic criteria in diagnosing Hashimoto’s
thyroiditis, and the diligence of the pathologist in searching
for thyroid cancer which may partly explain these diﬀer-
ences [16]. When the malignancies were analyzed sepa-
rately papillary carcinoma between 21–60 years and Non-
Hodgkin’s lymphoma in the 21–40 year age group showed
a statistically signiﬁcant association with Hashimoto’s thy-
roiditis. The association between Non-Hodgkin’s lymphoma
and preexisting Hashimoto’s thyroiditis has been well
recognized which is thought to develop from acquired
intrathyroidal lymphoid tissue in the setting of autoim-
mune thyroiditis [20–22]. The incidence of Hashimoto’s
thyroiditis in patients with lymphoma of the thyroid is 25%
[16].
Of the benign neoplasms a statistically signiﬁcant in-
crease of Hurthle cell adenoma was seen in association
with Hashimoto’s thyroiditis. Similar results were reported
in a study conducted by Dailey et al. [15]. Patients with
Hashimoto’s thyroiditis should therefore be observed closely
for coexistent neoplasia specially Non-Hodgkin’s lymphoma
and Hurthle cell adenoma.
Of the ancillary pathologies detected in this study
follicular carcinoma, medullary carcinoma, anaplastic car-
cinoma, follicular adenoma, multinodular goiter, colloid
goiter, colloid nodule, hyperplastic nodule, and benign
cysts showed no statistically signiﬁcant association with
Hashimoto’s thyroiditis. Of note was a branchial cyst in a
59-year-old female with which Hashimoto’s thyroiditis is
reported to be associated with [10, 11].
The limitations of this study are that this is based on a
pathological series and clinical details are not available. As
the study is based on surgically removed thyroid glands this
could have inﬂuenced the results. A study based on patients
with a clinical diagnosis of Hashimoto’s thyroiditis would
probably address this issue, avoiding the limitations of a
surgical bias.
Detection of ancillary pathologies in Hashimoto’s thy-
roiditis has diagnostic and prognostic implications. When
considering diagnosis, cytology plays an imminent role
where serological and imaging investigations are not freely
available as in Sri Lanka. The cytological features of
Hashimoto’s thyroiditis can overlap with features of lesions
such as follicular neoplasms, Hurthle cell neoplasm, papil-
lary, and goitrous nodules that can coexist with Hashimoto’s
thyroiditis[1,3,19].AlsocytologicalfeaturesofHashimoto’s
thyroiditis may dominate the smears and overshadow the
coexisting neoplasm causing false negative results. With
reference to prognosis it has been reported that malignant
neoplasms associated with Hashimoto’s thyroiditis are usu-
ally of lower grades of malignancy which relates to longer
survival of the patients [6, 15].
5. Conclusion
InconclusionthisstudyrevealedthatHashimoto’sthyroiditis
in the studied Sri Lankan population aﬀects patients in
the 4th to 6th decade of life with a female predominance.
Many malignant and benign neoplasms and other thyroid
pathologies coexist with Hashimoto’s thyroiditis and are
morecommoninpatientsover20yearsofageandinfemales.
A statistically signiﬁcantly higher percentage of papillaryJournal of Thyroid Research 5
carcinoma, Non-Hodgkin’s lymphoma and Hurthle cell ade-
noma were seen in association with Hashimoto’s thyroiditis
when compared with thyroids displaying other pathologies.
References
[1] S. M. Kollur, S. El Sayed, and I. A. El Hag, “Follicular thyroid
lesions coexisting with Hashimoto’s thyroiditis: incidence and
possible sources of diagnostic errors,” Diagnostic Cytopathol-
ogy, vol. 28, no. 1, pp. 35–38, 2003.
[2] S. D. Larson, L. N. Jackson, T. S. Riall et al., “Increased
incidence of well-diﬀerentiated thyroid cancer associated with
Hashimoto thyroiditis and the role of the PI3k/Akt pathway,”
Journal of the American College of Surgeons, vol. 204, no. 5, pp.
764–773, 2007.
[ 3 ]G . - K .N g u y e n ,J .G i n s b e r g ,P .M .C r o c k f o r d ,a n dR .R .
Villanueva, “Hashimoto’s thyroiditis: cytodiagnostic accuracy
and pitfalls,” Diagnostic Cytopathology, vol. 16, no. 6, pp. 531–
536, 1997.
[4] T. Akamizu, N. Y. Amino, and L. J. De Groot, “Hashimoto’s
thyroiditis,” http://www.thyroidmanager.org.
[5] G. Jayaram, K. R. Iyengar, P. Sthaneshwar, and J. N. Hayati,
“Hashimoto’sthyroiditis—aMalaysianperspective,”Journalof
Cytology, vol. 24, no. 3, pp. 119–124, 2007.
[6] M. A. Wijayawardena, H. D. Gunawardane, A. H. Sheriﬀdeen,
and M. V. de Silva, “Medullary carcinoma of the thyroid gland
associated with Hashimoto’s thyroiditis,” The Ceylon Medical
Journal, vol. 49, no. 3, p. 96, 2004.
[7] S. A. Wang, A. Rahemtullah, W. C. Faquin, J. Roepke, N. L.
Harris, and R. P. Hasserjian, “Hodgkin’s lymphoma of the
thyroid: a clinicopathologic study of ﬁve cases and review of
the literature,” Modern Pathology, vol. 18, no. 12, pp. 1577–
1584, 2005.
[ 8 ]J .K .C .C h a n ,J .A l b o r e s - S a a v e d r a ,H .B a t t i f o r a ,M .L .
Carcangiu, and J. Rosai, “Sclerosing mucoepidermoid thyroid
carcinoma with eosinophilia: a distinctive low-grade malig-
nancy arising from the metaplastic follicles of Hashimoto’s
thyroiditis,”AmericanJournalofSurgicalPathology,vol.15,no.
5, pp. 438–448, 1991.
[9] S.Sanchez-Sosa,N.P.Rios-Luna,B.D.R.Tamayo,K.Simpson,
and J. Albores-Saavedra, “Primary squamous cell carcinoma
of the thyroid arising in Hashimoto’s thyroiditis in an
adolescent,” Pediatric and Developmental Pathology, vol. 9, no.
6, pp. 496–500, 2006.
[10] E. Carter and O. Ulusarac, “Lymphoepithelial cysts of the
thyroid gland,” Archives of Pathology and Laboratory Medicine,
vol. 127, no. 4, pp. e205–e208, 2003.
[11] O. V. Moshynska and A. Saxena, “Clonal relationship between
Hashimoto thyroiditis and thyroid lymphoma,” Journal of
Clinical Pathology, vol. 61, no. 4, pp. 438–444, 2008.
[ 1 2 ] T .B .Be s t ,R .E .M u n r o ,S .B u rw ell ,a n dR .V o l pe ,“ R i ed el ’ st h y -
roiditis associated with Hashimoto’s thyroiditis, hypoparathy-
roidism, and retroperitoneal ﬁbrosis,” Journal of Endocrinolog-
ical Investigation, vol. 14, no. 9, pp. 767–772, 1991.
[13] M.-L. Shih, J. A. Lee, C.-B. Hsieh et al., “Thyroidectomy
for Hashimoto’s thyroiditis: complications and associated
cancers,” Thyroid, vol. 18, no. 7, pp. 729–734, 2008.
[ 1 4 ]K .M u g l e r ,L .G a i d o ,J .R y d e r ,a n dS .S a i d ,“ P l a s m ac e l l
granuloma of the thyroid with Hashimoto’s thyroiditis: report
of a rare case,” Ear, Nose and Throat Journal,v o l .8 2 ,n o .1 ,p p .
64–66, 2003.
[15] M. E. Dailey, S. Lindsay, and R. Skahen, “Relation of thyroid
neoplasms to Hashimoto’s disease of the thyroid gland,”
Archives of Surgery, vol. 70, no. 2, pp. 291–297, 1955.
[16] C. G. Thomas Jr. and R. G. Rutledge, “Surgical intervention in
chronic (Hashimoto’s) thyroiditis,” Annals of Surgery, vol. 193,
no. 6, pp. 769–776, 1981.
[17] Y. E. Nikiforov, “RET/PTC rearrangement—a link between
Hashimoto’s thyroiditis and thyroid cancer...or not,” Journal
of Clinical Endocrinology and Metabolism,v o l .9 1 ,n o .6 ,p p .
2040–2042, 2006.
[18] W. C. Shands, “Carcinoma of the thyroid in association with
struma lymphomatosa,” Annals of Surgery, vol. 151, no. 5, pp.
675–680, 1960.
[19] H. J. Carson, M. J. Castelli, and P. Gattuso, “Incidence of
neoplasia in Hashimoto’s thyroiditis: a ﬁne-needle aspiration
study,” Diagnostic Cytopathology, vol. 14, no. 1, pp. 38–42,
1996.
[20] J. S. Hahn, H. C. Chung, Y. H. Min et al., “Primary lymphoma
of the thyroid,” Yonsei Medical Journal, vol. 36, no. 4, pp. 315–
321, 1995.
[21] C. Luzel, Y. Kapran, G. Vural, and T. Terzioglu, “Primary
thyroid primary lymphoma: a report of two cases,” Turkish
Journal of Clinical Endocrinology and Metabolism, vol. 1, pp.
41–45, 2002.
[22] C. S. Raviprakash, C. Joseph, S. Xavier, and G. Raj, “Primary
Non-Hodgkin’s lymphoma of the thyroid with lymphocytic
thyroiditis,” Indian Journal of Otolaryngology and Head and
Neck Surgery, vol. 57, no. 3, pp. 257–259, 2005.